This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Public Health, Other  • Quality of Care  • Patient Safety/ Medical Error  • Alert me on articles by topic  Social Bookmarking   What's this?

Mike Mitka

JAMA. 2006;296:920-922.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A small cloud hovered over the June 30 celebration of the US Food and Drug Administration's (FDA) 100th anniversary in the form of a report, released 4 days earlier, that took the FDA to task for the agency’s lackluster enforcement of laws protecting the nation's food and medical products.

The report, issued by Rep Henry A. Waxman (D, Calif), said that during the past 5 years, the number of warning letters (a notice of violation of federal law) issued by the FDA to companies decreased by more than 50%. Waxman's report also said that officials at FDA headquarters routinely rejected the enforcement recommendations of the agency’s field staff and that the agency's recordkeeping and case tracking practices were inadequate.

The number of warning letters issued by the US Food & Drug Administration has declined over the past 5 years, while the number of violations observed by the agency . . . [Full Text of this Article]

WARNING LETTERS



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?